WELLS FARGO & COMPANY/MN - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$9,856
-22.2%
2,942
+0.8%
0.00%
Q2 2023$12,673
+16.0%
2,920
+0.2%
0.00%
Q1 2023$10,928
+6.3%
2,914
+0.1%
0.00%
Q4 2022$10,279
+71.3%
2,912
+0.1%
0.00%
Q3 2022$6,000
+20.0%
2,908
+0.1%
0.00%
Q2 2022$5,000
-44.4%
2,904
+0.4%
0.00%
Q1 2022$9,0002,892
+2735.3%
0.00%
Q4 2021$0102
+52.2%
0.00%
Q3 2021$067
+1575.0%
0.00%
Q2 2021$040.0%0.00%
Q1 2021$040.0%0.00%
Q4 2020$040.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 320,332$641,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 540,348$1,086,0000.06%
Eidelman Virant Capital 25,000$51,0000.04%
Diametric Capital, LP 24,548$49,0000.02%
MAI Capital Management 356,948$717,0000.01%
Bedel Financial Consulting, Inc. 15,000$31,0000.01%
Warberg Asset Management LLC 21,000$42,0000.01%
Cornerstone Capital, Inc. 13,857$28,0000.00%
Stokes Family Office, LLC 12,120$24,0000.00%
CarsonAllaria Wealth Management, Ltd. 1,000$2,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders